Загрузка...
Lapatinib: the evidence for its therapeutic value in metastatic breast cancer
INTRODUCTION: Breast cancer is the most common cancer affecting women. Many patients ultimately progress to metastatic disease and optimal management of this disease remains a significant therapeutic challenge. Lapatinib, a dual tyrosine kinase inhibitor, is in clinical development for treatment of...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2005
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3321658/ https://ncbi.nlm.nih.gov/pubmed/22500146 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|